Helium Health Co-Founder Adegoke Olubusi Steps Down as CEO
  • News
  • Africa

Helium Health Co-Founder Adegoke Olubusi Steps Down as CEO

His exit is part of a wider trend of founder departures in African healthtech.

8/12/2026
Ghita Khalfaoui
Back to News

Adegoke Olubusi, co-founder of Helium Health, has stepped down as Chief Executive Officer, marking a significant leadership change for the prominent Nigerian health-tech company. His departure reflects a broader trend of founder transitions occurring across Africa's maturing technology landscape. This move signals a new chapter for Helium Health as it navigates its next phase of growth and operational scaling.


A Leadership Transition at a Health-Tech Pioneer

Olubusi co-founded the company in 2016, and his exit follows that of fellow co-founder Tito Ovia in 2022, leaving Dimeji Sofowora as the sole founder in an active leadership role. The company has not yet publicly announced a successor or commented on the transition. This change places Helium Health at a critical inflection point regarding its future leadership and strategy.

Under Olubusi's guidance, Helium Health evolved from a startup digitizing hospital records into a leading digital health provider across Africa. After participating in Y Combinator in 2017, the company successfully raised over $50 million in venture capital. It now serves more than 10,000 healthcare providers with its suite of technology solutions.

Part of a Broader African Tech Trend

This leadership change is part of a larger pattern where several founding CEOs of major African startups have transitioned from their roles. This wave includes leaders from companies like Paga, Yoco, and Wasoko, indicating a collective maturation point for the ecosystem. These companies are now shifting from founder-led innovation to structured corporate scaling.

More specifically, Olubusi's departure highlights a concentration of such exits within the health-tech sector, following similar moves at mPharma and Lifestores Healthcare. This clustering suggests that health-tech companies face unique pressures accelerating these leadership changes. The sector is now undergoing a reckoning as it confronts the challenges of long-term sustainability.

Navigating Sector-Specific Challenges

African health-tech ventures contend with distinct obstacles, including high capital requirements and prolonged sales cycles with healthcare institutions. They must also navigate fragmented regulatory environments and slow procurement processes from public and private entities. These hurdles demand a shift towards rigorous operational management to ensure viability.

Investor expectations have evolved, with a growing emphasis on operational discipline and clear exit strategies over purely experimental growth. The current economic climate has amplified this demand for sustainable business models and proven commercial traction. Consequently, boards are seeking leaders with experience in scaling established organizations.

The Path Forward for Helium Health

As Helium Health considers its next leader, it may follow one of several models seen elsewhere in the ecosystem. The company could hire an experienced external operator, promote an internal executive for continuity, or conduct a global search for specific scaling expertise. This decision will be a crucial indicator of its strategic priorities.

The transition also raises important governance questions regarding the role of an outgoing founder who may retain influence. A new CEO's ability to implement changes could be complicated if clear lines of authority are not established. This challenge is pronounced in health-tech, where a founder's credibility is embedded in the company's fabric.


Adegoke Olubusi's departure from Helium Health is a pivotal moment for the company and a barometer for the African health-tech sector. The transition underscores the pressure on startups to evolve their leadership to meet the demands of scale and profitability. How Helium Health navigates this succession will be a critical test of its resilience and a closely watched case study.